Lv51
1300 积分 2025-06-25 加入
Overcoming breast cancer resistance through targeted protein degradation and next generation chimeras
3小时前
已完结
Targeting BRD4 in cancer therapy: From inhibitors and degraders to novel combination strategies and resistance mechanisms
3小时前
已完结
Bromodomain containing protein 4 (BRD4) and cancer therapy: A glimpse at dual-target drug development
3小时前
已完结
Targeting BRD4 bromodomains and beyond: exploring new therapeutic frontiers
3小时前
已完结
AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy
1个月前
已完结
Ginsenoside Rb1 attenuates diabetic peripheral neuropathy pathology by functioning as a potent activator of isocitrate dehydrogenase 1
1个月前
已完结
EP-0108A is a moderation selectively BRD4 BD2 inhibitor with potential AML tumor suppression
1个月前
已完结
Discovery of 2-(Pyrazol-4-yl)-quinazolin-4(3 H)-one Derivatives as Subnanomolar BRD4 BD2 Inhibitors with High Selectivity via a Bioisosterism Approach
1个月前
已完结
Marine natural product-inspired discovery of novel BRD4 inhibitors with anti-inflammatory activity
1个月前
已完结
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer
1个月前
已完结
皖公网安备34019202002308
